What we know so far: Coverage is forming - Foundayo was FDA approved April 1, 2026 Plan type matters - Large employers may have more flexibility Self-pay is affordable - $149-$349/month via LillyDirect (vs $1,000+ for injectable GLP-1s) Why this is good news Even without insurance coverage, Foundayo is one of the most affordable GLP-1 options available
Practical Allocation Guide: BPC 157 and TB 500 Dosage Protocol Developing an accurate bpc 157 and tb 500 dosage protocol requires careful calculation because the vial houses a unequal mass architecture (typically 10mg of BPC-157 paired with 20mg of TB-500)
SURPASS-2, NEJM 2021 An important caveat: semaglutides proven cardiovascular benefit is a meaningful clinical differentiator
both Willow and Gala connect patients with licensed healthcare providers who evaluate your eligibility, prescribe medication (if necessary), and monitor your progress
Dual agonists: Tirzepatide (GLP-1/GIP) and survodutide (glucagon/GLP-1)
As with any supplement or medication, individual responses vary